Therabot Study Flawed and Biased
A psychologist writes to say that our report on a randomized clinical trial for Therabot, an AI therapy chatbot, overlooked methodological weaknesses and researcher bias.
A psychologist writes to say that our report on a randomized clinical trial for Therabot, an AI therapy chatbot, overlooked methodological weaknesses and researcher bias.
A large number of mental illness cases happen outside the official diagnostic system, highlighting its inadequacies.
A letter from David Mou, MD, Chief Medical Officer of Cerebral.